LTRN
NASDAQ
$2.95
Lantern Pharma Inc (LTRN)
Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics, and machine learning. The company is headquartered in Dallas, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $20 (+577.97%)
Market Cap
$35M
FCF 5Y CAGR
+26.61%
Free Cash Flow Yield
-43.21%
Beta (5Y)
1.89
Price Chart
Valuation
Market Cap$35M
P/B11.33
Profitability
EBITDA-$17M
EPS-$1.44
Financial Health
Free Cash Flow Yield-43.21%
Growth & Risk
EPS 5Y CAGR+5.65%
FCF 5Y CAGR+26.61%
Beta (5Y)1.89
Sharpe Ratio0.12